2026-11-02 20:06:43 UTC#557817newconfirmednews
Altria (MO) stock news
Altria (MO) stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-31 01:52:09 UTC#549070newconfirmednews
UBS maintains Altria Group at Buy, raises price target to $83 from $79
2026-10-30 22:12:00 UTC#548649newconfirmednews
Citigroup maintains Altria Group at Neutral, raises price target to $72 from $70
2026-10-30 17:38:10 UTC#547410newconfirmednews
Morgan Stanley maintains Altria Group at Equal-Weight, raises price target to $77 from $71
2026-10-29 14:23:24 UTC#538181duplicateconfirmednews
Altria Group Inc reports Q3 adjusted EPS of $1.52 on $5.44 billion revenue
2026-10-29 11:59:00 UTC#536971duplicateconfirmednews
Altria Group reports Q3 profit of $2.52 billion and raises full-year earnings guidance
2026-10-29 11:36:27 UTC#536771duplicateconfirmednews
Altria Group Q3 2026 net revenue rises 1% to $6.1B, driven by smokeable products
2026-10-29 11:10:25 UTC#536488duplicateconfirmednews
Altria Q3 2026 Adj. EPS $1.52 vs $1.51 Est., Raises FY Adj. EPS Guidance to $5.66-$5.74
2026-10-29 11:06:03 UTC#536631duplicateconfirmednews
Altria Group Q3 adjusted EPS $1.52, raises FY 2026 guidance to $5.66–$5.74
2026-10-29 11:02:10 UTC#536478newconfirmeddata release
Altria Q3 2026 Non-GAAP EPS $1.52 beats by $0.01, Revenue $5.44B beats by $130M
2026-10-28 13:26:34 UTC#529225newconfirmednews
Altria Group (MO) Q3 2026 earnings preview: analysts expect 1.2% year-on-year revenue growth
2026-10-09 12:30:25 UTC#438243newconfirmednews
Altria Group extends $3 billion revolving credit agreement to October 2030
2026-09-23 19:51:29 UTC#358095duplicatereportednews
FDA plans to simplify and expedite review process for vapes and nicotine pouches, WSJ reports
fast_stock_market_newsimportance 0.40trust 0.60U.S. Food and Drug Administration +0.30Altria Group, Inc. +0.40NJOY Holdings, Inc. +0.40+2 entities
2026-09-21 16:29:00 UTC#343977duplicateconfirmednews
Turning Point Brands shares drop 13% following CEO change and EBITDA guidance cut
dow_jonesimportance 0.30trust 0.80Turning Point Brands, Inc. -0.80Altria Group, Inc. -0.30Philip Morris International Inc. -0.20+2 entities
2026-09-17 13:09:00 UTC#327778newconfirmedanalysis
Altria Group trades at 12.1x forward P/E, discount to sector and S&P 500, Zacks analysis shows
yahooimportance 0.30trust 0.50Altria Group, Inc. +0.20Philip Morris International Inc. 0Turning Point Brands, Inc. 0+2 entities
2026-09-14 08:31:00 UTC#305981newconfirmedanalysis
Zacks Industry Outlook: Philip Morris, British American Tobacco, and Altria navigate shifting tobacco landscape
yahooimportance 0.30trust 0.60Philip Morris International Inc. +0.10British American Tobacco p.l.c. +0.10Altria Group, Inc. +0.10+1 entities
2026-09-02 13:50:05 UTC#256280duplicateconfirmednews
Altria sues FDA to challenge tobacco product review process and application delays
reutersimportance 0.50trust 0.90Altria Group, Inc. +0.20U.S. Food and Drug Administration -0.20On! +0.30
2026-09-02 13:45:16 UTC#256268duplicateconfirmednews
Altria files lawsuit against US FDA over tobacco product review system
2026-09-02 13:44:18 UTC#256218newconfirmednews
Altria Group sues FDA to challenge legality of tobacco product premarket review system
fast_stock_market_newsimportance 0.60trust 0.60Altria Group, Inc. +0.30Food and Drug Administration -0.30
2026-09-02 13:41:29 UTC#256223duplicateconfirmednews